Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582179 · ClinicalTrials.gov registry record · NA
Vacuum Assisted Closure as a Treatment for Draining Hematomas
A NA study of Draining Hematoma, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
- 1
- Study location
NCT00582179: Completed NA study of Draining Hematoma, sponsored by University of Alabama at Birmingham.
NCT00582179 is a NA study of Draining Hematoma that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 94 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582179, a NA study of Draining Hematoma, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is designed as a prospective, randomized, comparative study evaluating the use of a negative pressure vacuum device in treating draining hematomas following traumatic injury.
Conditions Studied
Interventions
- PROCEDURE Standard Pressure Dressing
- DEVICE VAC
Study Locations (1)
Alabama
- The University of Alabama at Birmingham, Orthopaedic Trauma - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2001-09 |
| Est. Completion | 2007-03 |
| Phase | NA |
What the finished NCT00582179 record still lists
NCT00582179 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Draining Hematoma appearing as the primary indexed condition, and to 2 interventions - of which Standard Pressure Dressing is the first listed.
NCT00582179 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT00582179 about?
NCT00582179 is a clinical study titled "Vacuum Assisted Closure as a Treatment for Draining Hematomas". This project is designed as a prospective, randomized, comparative study evaluating the use of a negative pressure vacuum device in treating draining hematomas following traumatic injury.
What is the current status of trial NCT00582179?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2001-09. Estimated completion is 2007-03.
What conditions does trial NCT00582179 study?
This clinical trial studies the following conditions: Draining Hematoma.
What interventions are being tested in trial NCT00582179?
The interventions under investigation include: Standard Pressure Dressing (PROCEDURE), VAC (DEVICE).
Who is sponsoring clinical trial NCT00582179?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00582179 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00582179's enrollment target sits among peer trials
94 935th of 2000 higher than 1,064 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia